Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: Preliminary data of an open-label study

Neurological Sciences

Volumn 30, Issue 4, 2009, Pages 353-359

  Dinapoli, Loredana ^a   Maschio, Marta ^a   Jandolo, Bruno ^a   Fabi, Alessandra ^a   Pace, Andrea ^a   Sperati, Francesca ^a   Muti, Paola ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Brain tumor related epilepsy; Efficacy; Levetiracetam; Quality of life

Indexed keywords

ANTICONVULSIVE AGENT; CHLOROETHYLNITROSOUREA; ETIRACETAM; FOTEMUSTINE; OXCARBAZEPINE; PHENOBARBITAL; PROCARBAZINE; TEMOZOLOMIDE; TOPIRAMATE; VALPROIC ACID; VINCRISTINE;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE STUDY; CLINICAL ARTICLE; COGNITION; DISTRESS SYNDROME; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; OPEN STUDY; PERIARTHRITIS; PILOT STUDY; QUALITY OF LIFE; RESTLESSNESS; SEIZURE; SIDE EFFECT; SOMNOLENCE; WEIGHT REDUCTION;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTICONVULSANTS; BLOOD CELL COUNT; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; EPILEPSY; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERSONAL AUTONOMY; PIRACETAM; QUALITY OF LIFE; QUESTIONNAIRES; SEIZURES; YOUNG ADULT;

EID: 67650815220     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0087-x     Document Type: Article

References (24)

1. Edvardsson T, Ahlström G (2005) Illness-related problems and coping among persons with low-grade glioma. Psychooncology 14:728-737
2. Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low grade gliomas: A comparative study. Lancet 360:1361-1368
3. Mainio A, Hakko H, Timonen M, Niemelä A, Koivukangas J, Räsänen P (2005) Depression in relation to survival among neurosurgical patients with a primary brain tumor: A 5-year follow-up study. Neurosurgery 56:1234-1241
4. Lynam LM, Lyons MK, Drazkowski JF, Sirven JI, Noe KH, Zimmerman RS, Wilkens JA (2007) Frequency of seizures in patients with newly diagnosed brain tumors: A retrospective review. Clin Neurol Neurosurg 109:634-638
5. van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumors: Epidemiology, mechanisms, and management. Lancet Neurol 6:421-430
6. Maschio M, Albani F, Baruzzi A et al (2006) Levetiracetam therapy in patients with brain tumor and epilepsy. J Neurooncol 80:97-100
7. Klein M, Engelberts NH, van der Ploeg HM et al (2003) Epilepsy in low-grade gliomas: The impact on cognitive function and quality of life. Ann Neurol 54:514-520
8. Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 54:1886-1893
9. Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72:255-260
10. Contin M, Albani F, Riva R, Baruzzi A (2004) Levetiracetam therapeutic monitoring in patients with epilepsy: Effect of concomitant antiepileptic drugs. Ther Drug Monit 26:375-379
11. Maschio M, Dinapoli L, Zarabla A, Jandolo B (2006) Issues related to the pharmacological management of patients with brain tumors and epilepsy. Funct Neurol 21:15-19
12. Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78:99-102
13. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events v3.0, DCTD, NCI, NIH, DHHS. http://ctep.cancer.gov. Accessed 12 December 2003
14. Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P (1998) Evaluation of the EORTC QLQ-C30 questionnaire: A comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol 9:549-557
15. Cramer JA, Van Hammée G, N132 Study Group (2003) Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy Behav 4:118-123
16. Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H (2004) Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial. Neurology 62:23-27
17. Brown PD, Buckner JC, O'Fallon JR et al (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol 21:2519-2524
18. Karnofsky DA, Burchenal JH, Armistead GC, Southam CM, Bernstein JL, Craver LF, Rhoads CP (1951) Triethylene melamine in the treatment of neoplastic disease. Arch Int Med 87:477-516
19. Mahoney FI, Barthel DW (1965) Functional evaluation: The Barthel Index. Md State Med J 14:61-65
20. Beaumont A, Whittle IR (2000) The pathogenesis of tumor associated epilepsy. Acta Neurochir 142:1-15
21. Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, Löscher W (2007) Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 52:333-346
22. Brada M, Viviers L, Abson C et al (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715-1721
23. Perucca E, Meador KJ (2005) Adverse effects of antiepileptic drugs. Acta Neurol Scand Suppl 181:30-35
24. Meyers CA, Hess KR (2003) Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression. Neuro Oncol 5:89-95